chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt was trick or treating with family in his stroller, seemed "sad" then started B/L shaking which lasted about 30 sec. He was brought on the ground and costume removed. Ambulance brought to ED where reportedly temp was 104 and a sugar was WNL. Pt initially not very interactive but was released from ED after about an hour. He continued to have fever for about a day, then resolved. For past day has started to have runny nose and cough but no fever.
aching in bones; unable to sleep that night; extreme headache; extreme arm pain; barely able to lift arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (extreme arm pain), MOBILITY DECREASED (barely able to lift arm), BONE PAIN (aching in bones), INSOMNIA (unable to sleep that night) and HEADACHE (extreme headache) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PAIN IN EXTREMITY (extreme arm pain) and MOBILITY DECREASED (barely able to lift arm). On an unknown date, the patient experienced BONE PAIN (aching in bones), INSOMNIA (unable to sleep that night) and HEADACHE (extreme headache). On 27-Mar-2021, PAIN IN EXTREMITY (extreme arm pain), MOBILITY DECREASED (barely able to lift arm) and INSOMNIA (unable to sleep that night) had resolved. On 08-Apr-2021, BONE PAIN (aching in bones) had resolved. At the time of the report, HEADACHE (extreme headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Relevant concomitant medications was reported.  Treatment information was not provided.    This case was linked to MOD-2021-095628 (Patient Link).
Skin clammy. Pt felt flushed in face, metallic taste in mouth. Felt breathing was "a little heavy" P 80 BP 122/60 (2:00pm) P 74 BP 124/60 2:05 pm. Placed in laying position with feet elevated. Condition improved by 2:15 pm.
Rash on chest, neck, under breast.  Dryness around legs and face.  Also had fever 72 hours after injection.  Rash increased over last few days, not getting better.
Found dead Christmas morning; This spontaneous case was reported by a consumer and describes the occurrence of DEATH (Found dead Christmas morning) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Concurrent medical conditions included Diabetes mellitus.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. Death occurred on 25-Dec-2022 The patient died on 25-Dec-2022. The cause of death was not reported. It is unknown if an autopsy was performed.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment medication information was not provided by the reporter. It was reported that a coworker experienced the Same thing. A diabetic, he got the booster shot and was found dead Christmas morning.  Company commnent: This spontaneous case concerns a patient of unknown age and gender with medical history of diabetes mellitus, who experienced the unexpected, serious (fatal and medically significant) event of death. The event occurred an unknown time after a dose of mRNA-1273.222. Cause of death was not reported (unknown). Information regarding clinical evaluation, autopsy report, diagnostic tests, concomitant medications, and treatment provided has not been disclosed. The medical history of diabetes mellitus is a confounder. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns a patient of unknown age and gender with medical history of diabetes mellitus, who experienced the unexpected, serious (fatal and medically significant) event of death. The event occurred an unknown time after a dose of mRNA-1273.222. Cause of death was not reported (unknown). Information regarding clinical evaluation, autopsy report, diagnostic tests, concomitant medications, and treatment provided has not been disclosed. The medical history of diabetes mellitus is a confounder. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Reported Cause(s) of Death: Unknown cause of death
Red, itchy,slightly tinted rash on his collar bone and the top of his sternum; Tingling sensation; Red, itchy,slightly tinted rash on his collar bone and the top of his sternum; Slightly tinted rash on his collar bone and the top of his sternum; The rash increasingly spread to his stomach with a lighter rash in places around his under arm but not in his arm pit, down his arm, and down the side of his torso; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Red, itchy,slightly tinted rash on his collar bone and the top of his sternum), PARAESTHESIA (Tingling sensation), ERYTHEMA (Red, itchy,slightly tinted rash on his collar bone and the top of his sternum), RASH (Slightly tinted rash on his collar bone and the top of his sternum) and RASH (The rash increasingly spread to his stomach with a lighter rash in places around his under arm but not in his arm pit, down his arm, and down the side of his torso) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 028L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (Red, itchy,slightly tinted rash on his collar bone and the top of his sternum), PARAESTHESIA (Tingling sensation), ERYTHEMA (Red, itchy,slightly tinted rash on his collar bone and the top of his sternum), RASH (Slightly tinted rash on his collar bone and the top of his sternum) and RASH (The rash increasingly spread to his stomach with a lighter rash in places around his under arm but not in his arm pit, down his arm, and down the side of his torso). The patient was treated with HYDROCORTISONE ongoing since an unknown date for Rash, at an unspecified dose and frequency and LORATADINE (CLARITIN [LORATADINE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PRURITUS (Red, itchy,slightly tinted rash on his collar bone and the top of his sternum), PARAESTHESIA (Tingling sensation), ERYTHEMA (Red, itchy,slightly tinted rash on his collar bone and the top of his sternum), RASH (Slightly tinted rash on his collar bone and the top of his sternum) and RASH (The rash increasingly spread to his stomach with a lighter rash in places around his under arm but not in his arm pit, down his arm, and down the side of his torso) outcome was unknown.            The concomitant medications were not provided.  Treatment medication also included antifungal cream.
Started having symptoms of shingles, a pustule like rash appeared under left arm. Had a sore arm from shot prior to shingles symptoms.
Diarrhea; Chills; Body aches; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), CHILLS (Chills), MYALGIA (Body aches) and VOMITING (Vomiting) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), CHILLS (Chills), MYALGIA (Body aches) and VOMITING (Vomiting). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea), CHILLS (Chills), MYALGIA (Body aches) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
headache; Body aches; sore throat/post nasal drip; This is a spontaneous report from a contactable Other HCP (patient). A 38-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via unspecified route of administration on left arm on 06Feb2021 16:00 (at the age of 61-year-old) at single dose for Covid-19 immunization. The patient medical history included Allergy to nuts. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via unspecified route of administration on left arm on 16Jan2021 16:00 (at the age of 61-year-old) at single dose for Covid-19 immunization. Concomitant medication were not reported. The patient reported, body aches and headache. 1 week after the second dose, sore throat/post nasal drip and headache on 07Feb2021. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any treatment for the event. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient has not been tested for COVID-19. The outcome of event was not recovered.   Information about lot/batch number has been requested.
Patient received vaccine the 28th of December 2020. Physical exam show erythema, warm to touch, itching, slightly raised area and blanching to palpation. Circle drawn around redness previous night (2inx1.5in approx) and redness has progressed to larger diameter . Denies pain at sight. Patient has long painted nails. Patient given oral antibiotics, cephalexin 500mg taken 4 times a day for 10 days as well as topical steroid cream, triamcin acet 0.025% to be applied to area twice a day for 2 days. Instructed to follow up in two days to evaluation. During follow up, area noted to be improving. Instructed to continue current treatment and return if worsening of symptoms or development of new symptoms, fever/chills.
super tired.; This case was reported by a consumer via  interactive digital media and described the occurrence of tiredness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced tiredness. On an unknown date, the outcome of the tiredness was recovered/resolved.   It was unknown if the reporter considered the tiredness to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got the shingles shot and that left him/her super tired. The patient advised to take vaccine when you could take a couple days off. The follow-up would not possible as no contact details were available. For tolerance to 2nd dose, refer case US2021AMR183058.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR183058:same patient same reporter US-GLAXOSMITHKLINE-US2021AMR183058:same patient, same reporter
48 hours after vaccination, developed swollen lymph nodes on right neck (front and back); Red rash spots on neck; 8 hours after, started to feel asthma; Felt like when exposed to a lot of dust and very allergic to dust mites; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received first dose of BNT162b2 (COVID-19 MRNA VACCINE BIONTECH; Lot number: ER8730) via unspecified route of administration in left arm on 22Mar2021 at 08:00 as a single dose (at the age of 56-years-old) for COVID-19 immunisation. The patient had known allergies to sulfonamides and monosodium glutamate. The patients medical history included hypertension and asthma. The concomitant medications included valsartan (MANUFACTURER UNKNOWN) 180 mg used once daily for an unknown indication and multivitamin for women (MANUFACTURER UNKNOWN) for an unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 22Mar2021 at 15:00, 8 hours after the vaccine shot, the patient felt the asthma as she has allergic asthma and felt like when she was exposed to a lot of dust as she was very allergic to dust mites; On 24Mar2021 at 08:00, 48 hours after the shot, the patient experienced swollen lymph nodes on right neck (front and back) and red rash spots on the neck. No treatment was received for the events. The clinical outcome of the reported events was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
No additional AE reported; Patient was administered improperly stored VAQTA; This spontaneous report was received from a registered nurse, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent condition, drug reactions/allergies and concomitant medication was not provided.  On 14-FEB-2022, the patient was vaccinated with improperly stored hepatitis a vaccine, inactivated (VAQTA) (lot # U024504, expiration date 15-OCT-2022, doses, strengths and route were not provided) for prophylaxis (product storage error). The vaccines administered experienced temperature excursions of 0.8 Degree Celsius for 35 minutes on 05-FEB-2022. There was no previous temperature excursion. No additional adverse event reported.  This is one of multiple cases received from the same reporter. ; Sender's Comments:  US-009507513-2203USA003820: US-009507513-2203USA003814: US-009507513-2203USA003938: US-009507513-2203USA003853: US-009507513-2203USA003841: US-009507513-2203USA003951:
This spontaneous report was received from a medical assistant calling on behalf of physician regarding a 18 year old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications and drug/allergies were not reported. On 31-MAY-2018, the patient was vaccinated with GARDASIL 9 lot # N020138, expiry date: 14-FEB-2020, dose 1 for prophylaxis. On 31-MAY-2018, after 20 minutes of administration of the first dose of the GARDASIL 9 the patient developed temperature of 103 Fahrenheit (F) (pyrexia). On 07-AUG-2018, the patient was vaccinated GARDASIL 9 lot # N028567, expiry date: 17-MAY-2020 (route not reported) dose 2 for prophylaxis. On 07-AUG-2018, after 20 minutes of administration of the second dose of the GARDASIL 9 patient developed temperature of 105.7 Fahrenheit (F) (pyrexia). Outcome of pyrexia was unknown. Causality assessment was not reported.
Redness, swelling right thigh, "overlying redness, underlying induration". Nontender, afebrile, no streaks-Photo taken to indicate redness.
Patient got ZOSTAVAX vaccine on 9/15/2013. On 9/15/2013 she started develop redness, soreness and swelling at injection site (left arm). On 9/20/13 Patient reported to pharmacy.
Hives covering torso - given 4CC Oropred and a 6 day course.
Exactly four hours after flu shot administered, lymph nodes in throat and tongue began to swell. Difficulty swallowing. Two hours later his eyes swelled, became extremely bloodshot and leaked fluid that became instantly crusty. Body ached on right side of body through abdomen. Heart rate increased: normal 46-48 bpm to 84 bpm. No fever. No cough.
patient started having hives on his face and body 10 minutes after receiving Kinrix and MMRV vaccines.  PCP notified right away, vital signs taken as below, lung sound listened, benedryl 6ml given PO. vital signs: 3:35pm: O2 99%, HR 106 3:40pm: O2 100%, HR 97 3:53PM: O2-100% 4:00PM: BP- 90/54 right 4:15PM: O2-100%, HR-104, pt left the clinic with stable condition.   patient had f/u visit with PCP on 06/04/2023.  patient took benadryl in office on 06/03/2023 and after 6 hours the rashes resolved when patient got home and never returned. patient is doing well.
COVID INFECTION, MILD DYSPNEA, LOSS OF TASTE, CHILLS  Narrative: COVID infection after completion of COVID vaccine series 02/23 COVID vaccine dose #1 03/16 COVID vaccine dose #2 03/31 visit by patient's cousin, who developed symptoms after visit 04/06 COVID positive, reports mild dyspnea 04/07 reports ongoing dyspnea, diarrhea x 1, loss of taste 04/08 worsening shortness of breath 04/10 pt feeling a lot better, no SOB, no body aches, temp wnl 04/12 covid infection clinically resolved
0909A Gave Tdap, TWINRIX #3 and intradermal FLUZONE without difficulty. Several minutes later client c/o feeling warm and closed eyes but remained conscious answered verbal commands while diaphoretic and warm. Gave sip H2O and cold pack to cool self. At 918A - 920A client c/o difficulty breathing without retractions, cyanosis or wheezing. Called for RN backup and clerical called 911. P 100, BP 100/46. EMS here at 925A, gave nasal O2 and transported to ER.
Swelling and warm to touch in deltoid after night of vaccine - pt was given oral BENADRYL 25mg po. in office as well as DECADRON 12mg po.
during the administration of Shingrix the syringe leak; This case should be considered invalid because the amount of leakage is not specified also the replacement dose was not mentioned.
Got my Moderna vaccine, first dose on Friday 3/26/21. A week later, the following Friday on 4/2/21 at around 11pm, I started getting the chills with a fever and a rash on my ankles, feet and legs. Fever and chills were gone the next morning but I woke up with a horrible headache. Rash lasted for a few days.
PATIENT PASSED OUT AND EXPERIENCED CONVULSIONS APPROXIMATELY 1-2 MINUTES POST VACCINATION. HE WAS UNRESPONSIVE FOR 5 - 10 SECONDS AND THEN BECAME ALERT COMPLAINING OF "FEELING HOT" AND HAD TROUBLE BREATHING. EMS WAS CALLED AND PATIENT WAS TRANSPORTED TO LOCAL HOSPITAL.
Fever; fatigue; body aches; This is a spontaneous report from a contactable physician via Pfizer Sales Representative (patient). This Physician (Patient) reported similar events for 2 patients (Herself and Husband). This female Physician reported for herself. A female patient of an unspecified age received dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced fever, fatigue, body aches. It was further reported that She reported that both she and her husband both experienced side effects after receiving each shot. Symptoms included. Fever, fatigue and body aches. Symptoms was appeared after 1/2 of getting the shot and lasted a day and the event took place after use of product. The clinical outcome for all the events was reported as recovered.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021338743 same reporter/product/event, different patient
Beginning 6:30pm noticed extreme soreness on 10/22/01 R deltoid and progressed over the night to soreness and erythema & edema R upper arm from deltoid to elbow. Pain and above sx's continue as of 10:20 on 10/24/2001. Took 3 advil at 9am 10/24/2001.
Sever nausea, vomiting, diarrhea, extreme thirst, high grade fever 102.5, Tylenol would not bring the fever down, chills, shaking, confusion, BRAIN ZAPS which I?ve only ever experienced when coming off of a psych medication, severe body aches, can?t wear clothes because it hurts, headache, scratchy throat, sever sensitivity to smells, I will vomit when I smell food etc.
ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 12/16/2021 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY  ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/16/2021 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY
This spontaneous report as received from a medical assistant who was also the office manager refers to a gender unspecified patient of unspecified age with no pertinent medical history or any drug reactions/allergies. Medical assistant reported that sometime in September 2008, the patient received the first dose of GARDASIL (dose, route and lot # not reported). Sometime in February 2009, the patient received the second dose of GARDASIL (dose, route and lot # not reported) which was late. The third dose had not been administered at the time of report. No other co-suspects were reported. No concomitant medications were reported. No symptoms reported. No treatment information was reported. Laboratory tests were reported as not applicable. Additional information has been requested.
(Note; after 1st dose on February 1st had some tongue and lip tingling within 30 minutes,  took Benadryl 25 mg with relief).  Prior to second dose, took Benadryl 25 mg at 310pm.... at 350pm, received second dose of Pfizer vaccine.... tingling of lips and tongue within 10 minutes, took Benadryl 25 mg at 4pm...?. progression of tingling of tongue to some numbness of tongue, towards back of throat, some difficulty swallowing, throat hoarseness, chest discomfort, sporatic spot itching of eyeballs - shoulder-forehead-top of right arm.   Went to Emergency room around 5pm.... given corticosteroid and Pepcid IV... with relief.  Left Emergency room around 730 with minimal tingling of tongue....no other symptoms.   Took Benadryl 25 mg by mouth before bed.   3/6/21- woke up with no symptoms.
Pt complained of upper respiratory signs and symptoms on 3/6/03. Developed 100F fever and red lesions on 3/8/03. Red lesions on R neck,chest, hand, leg and one lesion on tongue. Pt was sent to ER on 3/8/03 for evaluation. Pt was instructed to take benadryl and released from ER. As of 3/10/03, pt reports no new lesions, no fever and only headache and myalgia. She also reports lesions are becoming smaller and less inflamed. Pt to follow up with MD
The next day after the vaccine I began having a low grade fever low around 100.2, my arm was sore for about 3-4 days. Body aches and soreness lasted about a week. But the fatigues and dizziness came also and still to date I am still suffering from both. No matter what I do I still feel very fatigued and get dizzy often. I saw the Neurologist on 7/26 for the dizziness because I have fallen 2 different times resulting in a cracked tailbone and various bruising. I was then referred for physical therapy at Total Rehab which I am still going to date, as well. My PT states I have weakness that has developed on my left side with no significant cause. States my balance and gate is off and is currently treating me for Gate Abnormality and dizziness and my body feels very weak lots of days. On 8/9  I say my Rheumatologist who performed various lab work and inflammation markers. Stated my SED rate was elevated indicating inflammation in my body. An MRI was performed and my vision was also checked as a precaution, but now I have a blind spot that has developed in my right eye next to my Optic Nerve which has never been there, but states the Optic nerve does not have any pressure on it, but is unsure if it is related but it did not appear until after the vaccine. I have to now go see a Neurosurgeon to ensure I am not developing blindness.
Sudden onset High Fever 103, immediately gave children's Tylenol, alternated Children's Tylenol & Children's Motrin Q4H. By 4am Sunday morning, fever was 103 even with medicine. Other symptoms at this time runny nose, congestion, violent coughing, vomiting (mostly mucus), lathargy, one eye looked a little infected with greenish discharge. High fever lasted until Tuesday around 8:00pm. (4 days) Was giving Tylenol/Motrin Q 3 hours Sunday-Tuesday as recommended by ER doctor.
None. Urticarial rash-face. BENADRYL. Ibuprofen.